Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Sector
Healthcare
Region
US
AUM
178.36M
Fund Score
SPDR S&P Pharmaceuticals ETF (ARCA:XPH) Quotes, Forecast and News Summary
SPDR S&P Pharmaceuticals ETF (ARCA: XPH) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | $48.76 |
| AUM | 178.36M |
| Dividend | $0.62 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | - |
| Market Cap | $77.80B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 16.08 |
| Prev. Close | $46.34 |
| Low | - |
| 52 Wk Low | $36.49 |
| Shares Out | 4.85M |
| Yield | 1.48% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 50.77K |
| Beta | 0.76 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | - |
Recent News
FAQ
Q
How do I buy SPDR S&P Pharmaceuticals ETF (XPH) stock?
A
You can purchase shares of SPDR S&P Pharmaceuticals ETF (ARCA:XPH) through any online brokerage.
Q
Who are SPDR S&P Pharmaceuticals ETF (XPH) competitors?
A
There are no as such competitors for SPDR S&P Pharmaceuticals ETF.
Q
What is the forecast, or price target, for SPDR S&P Pharmaceuticals ETF (XPH) stock?
A
There is no analysis for SPDR S&P Pharmaceuticals ETF to provide a consensus price target.
Q
What is the current price for SPDR S&P Pharmaceuticals ETF (XPH)?
A
The stock price for SPDR S&P Pharmaceuticals ETF (ARCA: XPH) is $46.34 last updated November 21, 2024 at 8:00 PM EST.
Q
Does SPDR S&P Pharmaceuticals ETF (XPH) pay a dividend?
A
A quarterly cash dividend of 0.05 per share of Class A Common Stock. The quarterly cash dividend was payable on September 27, 2018 to stockholders of record on September 24, 2018.
Q
When is SPDR S&P Pharmaceuticals ETF (ARCA:XPH) reporting earnings?
A
SPDR S&P Pharmaceuticals ETF does not have any upcoming earnings scheduled.
Q
Is SPDR S&P Pharmaceuticals ETF (XPH) going to split?
A
There is no upcoming split for SPDR S&P Pharmaceuticals ETF.
| Open | - |
| High | - |
| 52 Wk High | $48.76 |
| AUM | 178.36M |
| Dividend | $0.62 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | - |
| Market Cap | $77.80B |
| Mgmt Fee | 0.35% |
| P/E Ratio | 16.08 |
| Prev. Close | $46.34 |
| Low | - |
| 52 Wk Low | $36.49 |
| Shares Out | 4.85M |
| Yield | 1.48% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 50.77K |
| Beta | 0.76 |
| Avg. Expense Ratio | 0.35% |
| P/B Ratio | - |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Blend |
| Fund Inception | Jun 19, 2006 |
| Managers | Keith Richardson Karl A. Schneider |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved